Roman Necina
Operationeel Directeur bij HOOKIPA PHARMA INC.
Vermogen: 11 990 $ op 30-04-2024
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Jörn Aldag | M | 65 | 8 jaar | |
Jan van de Winkel | M | 63 | 7 jaar | |
Reinhard Kandera | M | 54 | 7 jaar | |
Julie O'Neill | F | 58 | 6 jaar | |
Mary Coelho | F | 62 | 1 jaar | |
Tony Melckenbeek | M | - | - | |
Klaus Orlinger | M | 46 | 12 jaar | |
David Kaufman | M | 51 | 5 jaar | |
Timothy Reilly | M | 50 | 2 jaar | |
Norbert Riedel | M | 66 |
Austrian Academy of Sciences
Austrian Academy of Sciences Miscellaneous Commercial ServicesCommercial Services The Austrian Academy of Sciences provides humanities and social science research services. The private company is based in Vienna, Austria. | 15 jaar |
Victor Paulus | M | - | 6 jaar | |
Karin Schaupp | M | 74 |
Austrian Academy of Sciences
Austrian Academy of Sciences Miscellaneous Commercial ServicesCommercial Services The Austrian Academy of Sciences provides humanities and social science research services. The private company is based in Vienna, Austria. | - |
Malte Peters | M | 61 | 1 jaar | |
Monika Henzinger | M | 58 |
Austrian Academy of Sciences
Austrian Academy of Sciences Miscellaneous Commercial ServicesCommercial Services The Austrian Academy of Sciences provides humanities and social science research services. The private company is based in Vienna, Austria. | - |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Michael Kelly | M | 67 | 4 jaar | |
Daniel D. Pinschewer | M | 49 | 8 jaar | |
Christine Baker | F | 58 | 5 jaar | |
Jean-Charles Soria | M | 53 | - | |
Christoph S. Lengauer | M | 59 | 4 jaar | |
Katia Schlienger | M | 62 | 2 jaar | |
Graziano Seghezzi | M | 55 | 10 jaar | |
Sander J. van Deventer | M | 69 | 9 jaar | |
Thomas D. Szucs | M | 64 |
Intercell AG
Intercell AG Pharmaceuticals: MajorHealth Technology Intercell AG engages in the research, development, manufacture, and marketing of novel vaccines for the prevention and treatment of infectious diseases. Its products include Japanese encephalitis vaccine, Pseudomonas vaccine, Clostridium difficile vaccine, tuberculosis vaccine, and pandemic influenza vaccine patch. Its technology platforms involve patch-based delivery system and proprietary human monoclonal antibody discovery system. The company was founded by Alexander von Gabain, Max Birnstiel, Michael Buschle, Walter Schmidt, and Aaron Hirsh on December 3, 1997 and is headquartered in Vienna, Austria. | 2 jaar |
Anders Lilja | M | - | 7 jaar | |
Gerd Zettlmeissl | M | 68 |
Intercell AG
Intercell AG Pharmaceuticals: MajorHealth Technology Intercell AG engages in the research, development, manufacture, and marketing of novel vaccines for the prevention and treatment of infectious diseases. Its products include Japanese encephalitis vaccine, Pseudomonas vaccine, Clostridium difficile vaccine, tuberculosis vaccine, and pandemic influenza vaccine patch. Its technology platforms involve patch-based delivery system and proprietary human monoclonal antibody discovery system. The company was founded by Alexander von Gabain, Max Birnstiel, Michael Buschle, Walter Schmidt, and Aaron Hirsh on December 3, 1997 and is headquartered in Vienna, Austria. | 10 jaar |
Werner Lanthaler | M | 56 |
Intercell AG
Intercell AG Pharmaceuticals: MajorHealth Technology Intercell AG engages in the research, development, manufacture, and marketing of novel vaccines for the prevention and treatment of infectious diseases. Its products include Japanese encephalitis vaccine, Pseudomonas vaccine, Clostridium difficile vaccine, tuberculosis vaccine, and pandemic influenza vaccine patch. Its technology platforms involve patch-based delivery system and proprietary human monoclonal antibody discovery system. The company was founded by Alexander von Gabain, Max Birnstiel, Michael Buschle, Walter Schmidt, and Aaron Hirsh on December 3, 1997 and is headquartered in Vienna, Austria. | 9 jaar |
David Ebsworth | M | 69 |
Intercell AG
Intercell AG Pharmaceuticals: MajorHealth Technology Intercell AG engages in the research, development, manufacture, and marketing of novel vaccines for the prevention and treatment of infectious diseases. Its products include Japanese encephalitis vaccine, Pseudomonas vaccine, Clostridium difficile vaccine, tuberculosis vaccine, and pandemic influenza vaccine patch. Its technology platforms involve patch-based delivery system and proprietary human monoclonal antibody discovery system. The company was founded by Alexander von Gabain, Max Birnstiel, Michael Buschle, Walter Schmidt, and Aaron Hirsh on December 3, 1997 and is headquartered in Vienna, Austria. | 8 jaar |
Katherine Cohen | M | - |
Intercell AG
Intercell AG Pharmaceuticals: MajorHealth Technology Intercell AG engages in the research, development, manufacture, and marketing of novel vaccines for the prevention and treatment of infectious diseases. Its products include Japanese encephalitis vaccine, Pseudomonas vaccine, Clostridium difficile vaccine, tuberculosis vaccine, and pandemic influenza vaccine patch. Its technology platforms involve patch-based delivery system and proprietary human monoclonal antibody discovery system. The company was founded by Alexander von Gabain, Max Birnstiel, Michael Buschle, Walter Schmidt, and Aaron Hirsh on December 3, 1997 and is headquartered in Vienna, Austria. | 11 jaar |
Matthew Beck | M | - | 4 jaar | |
Gregory Glenn | M | 70 |
Intercell AG
Intercell AG Pharmaceuticals: MajorHealth Technology Intercell AG engages in the research, development, manufacture, and marketing of novel vaccines for the prevention and treatment of infectious diseases. Its products include Japanese encephalitis vaccine, Pseudomonas vaccine, Clostridium difficile vaccine, tuberculosis vaccine, and pandemic influenza vaccine patch. Its technology platforms involve patch-based delivery system and proprietary human monoclonal antibody discovery system. The company was founded by Alexander von Gabain, Max Birnstiel, Michael Buschle, Walter Schmidt, and Aaron Hirsh on December 3, 1997 and is headquartered in Vienna, Austria. | 2 jaar |
Igor Matushansky | M | 51 | 5 jaar | |
Gwenaelle Kerforn | F | - | 3 jaar | |
Nina Waibel | F | - | 3 jaar |
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Verenigde Staten | 24 | 72.73% |
Oostenrijk | 9 | 27.27% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Roman Necina
- Persoonlijk netwerk